Skip to main content
Veterinary Medicines

Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle

Authorised
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate

Product identification

Medicine name:
Addimag 160 mg/ml + 84 mg/ml roztwór do infuzji dla bydła
Addimag 160 mg/ml + 84 mg/ml solution for infusion for cattle
Active substance:
  • Magnesium chloride hexahydrate
  • Calcium gluconate monohydrate
Target species:
  • Cattle
Route of administration:
  • Intravenous use

Product details

Active substance and strength:
  • Magnesium chloride hexahydrate
    84.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate monohydrate
    160.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Alfasan Nederland B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Alfasan Nederland B.V.
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3195
Date of authorisation status change:
Reference member state:
  • Netherlands
Procedure number:
  • NL/V/0352/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
Generic of:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."